Marijuana Company of America, Inc. (MCOA) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Marijuana Company of America, Inc. (MCOA), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026Marijuana Company of America, Inc. (MCOA) Sağlık ve Boru Hattı Genel Bakışı
Marijuana Company of America, Inc. focuses on developing and distributing cannabis and CBD products under the hempSMART brand, targeting the wellness market through online and affiliate channels, while facing significant challenges in profitability and market competition within the specialty drug manufacturing sector.
Yatırım Tezi
Investing in Marijuana Company of America, Inc. presents significant risks due to its negative profitability and high beta of 9.91, indicating extreme volatility relative to the market. The company's negative profit margin of -1441.1% and gross margin of -74.1% raise concerns about its financial sustainability. Growth depends on successful expansion of the hempSMART product line and effective marketing strategies to increase sales through online and affiliate channels. Potential investors should carefully consider the risks associated with OTC-listed companies and the competitive landscape of the cannabis and CBD market. The company's small size, with only 7 employees, also poses operational challenges.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.09 reflects negative earnings and challenges in achieving profitability.
- Profit margin of -1441.1% highlights significant losses and operational inefficiencies.
- Gross margin of -74.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's business model.
- Beta of 9.91 suggests extreme volatility compared to the broader market, making it a high-risk investment.
Rakipler & Benzerleri
Güçlü Yönler
- Established hempSMART brand.
- Proprietary formulations like hempSMART Brain.
- Distribution network through cdistro.com.
- Direct-to-consumer sales channel.
Zayıflıklar
- Negative profitability and gross margins.
- High beta indicating extreme volatility.
- Limited financial resources.
- Small employee base.
Katalizörler
- Upcoming: Potential legalization of cannabis at the federal level in the U.S., which could significantly expand the market for MCOA's products.
- Ongoing: Expansion of the hempSMART product line to include new formulations and delivery methods.
- Ongoing: Strategic partnerships and distribution agreements to increase market reach.
- Ongoing: Enhanced e-commerce and digital marketing efforts to drive online sales.
- Ongoing: International expansion into legal cannabis markets.
Riskler
- Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.
- Potential: Complex and evolving regulatory landscape, which could impact MCOA's ability to operate and sell its products.
- Potential: Fluctuations in consumer demand for cannabis and CBD products.
- Potential: Potential for product recalls or safety concerns, which could damage MCOA's brand reputation.
- Ongoing: Negative profitability and gross margins, which could threaten MCOA's financial sustainability.
Büyüme Fırsatları
- Expansion of hempSMART Product Line: MCOA has the opportunity to expand its hempSMART product line to cater to a broader range of consumer needs. By introducing new formulations and delivery methods, such as edibles or topicals, MCOA can attract new customers and increase sales. The global CBD market is projected to reach $16 billion by 2028, providing a substantial market opportunity for MCOA to capitalize on. This expansion requires investment in research and development and effective marketing strategies.
- Strategic Partnerships and Distribution Agreements: MCOA can pursue strategic partnerships and distribution agreements to expand its reach and access new markets. Collaborating with established retailers or distributors can provide MCOA with access to a wider customer base and increase brand awareness. The company can also explore partnerships with healthcare providers or wellness centers to promote its products. These partnerships can be established within the next 1-2 years, driving revenue growth and market penetration.
- International Expansion: MCOA can explore international expansion opportunities in countries where cannabis and CBD products are legal. By entering new markets, MCOA can diversify its revenue streams and reduce its reliance on the U.S. market. The European CBD market, for example, is experiencing rapid growth, presenting a significant opportunity for MCOA. This expansion will require careful consideration of regulatory requirements and market dynamics in each country.
- Focus on E-commerce and Digital Marketing: MCOA can enhance its e-commerce platform and digital marketing efforts to drive online sales. By optimizing its website for search engines and investing in targeted advertising campaigns, MCOA can attract more customers and increase conversion rates. The company can also leverage social media platforms to engage with customers and build brand awareness. These digital strategies can be implemented within the next 6-12 months, leading to increased online sales and customer engagement.
- Development of Proprietary Formulations and Intellectual Property: MCOA can invest in research and development to create proprietary formulations and intellectual property for its products. By developing unique and differentiated products, MCOA can establish a competitive advantage and protect its market share. The company can also seek patents for its formulations and technologies, further strengthening its intellectual property portfolio. This long-term strategy can enhance MCOA's brand reputation and attract investors.
Fırsatlar
- Expansion of hempSMART product line.
- Strategic partnerships and distribution agreements.
- International expansion into legal cannabis markets.
- Enhanced e-commerce and digital marketing efforts.
Tehditler
- Intense competition in the cannabis and CBD market.
- Complex and evolving regulatory landscape.
- Fluctuations in consumer demand.
- Potential for product recalls or safety concerns.
Rekabet Avantajları
- Brand recognition of hempSMART products.
- Proprietary formulations, including hempSMART Brain.
- Established distribution network through cdistro.com.
- Affiliate marketing program driving sales.
MCOA Hakkında
Marijuana Company of America, Inc. (MCOA) was founded in 1985 as Converge Global, Inc., before rebranding in December 2015 to capitalize on the emerging cannabis and CBD market. The company develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand within the United States. MCOA's product line includes hempSMART Brain, a patented personal care product for brain wellness; hempSMART Pain capsules and cream for discomfort relief; hempSMART Drops, a hemp CBD oil tincture; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, a powderized CBD drink. These products are primarily sold through the company's website and affiliate marketing programs. Additionally, MCOA distributes hemp and CBD products, including smoke and vape shop related items, to wholesalers, c-stores, specialty retailers, and consumers through its cdistro.com platform. Headquartered in Los Angeles, California, MCOA aims to establish a presence in the growing CBD and cannabis wellness market.
Ne Yaparlar
- Develops and produces cannabis and cannabidiol (CBD) products.
- Distributes products under the hempSMART brand.
- Offers hempSMART Brain for brain wellness.
- Provides hempSMART Pain capsules and cream for discomfort relief.
- Sells hempSMART Drops, a hemp CBD oil tincture.
- Markets hempSMART Pet Drops for cats and dogs.
- Offers hempSMART Face, a facial moisturizer.
- Distributes hemp and CBD products through www.cdistro.com.
İş Modeli
- Develops and manufactures hempSMART branded CBD and cannabis products.
- Sells products directly to consumers through its website.
- Distributes products through affiliate marketing programs.
- Wholesales hemp and CBD products to retailers via cdistro.com.
Sektör Bağlamı
Marijuana Company of America, Inc. operates in the rapidly evolving cannabis and CBD market, which is characterized by increasing consumer demand for wellness products. The industry is highly competitive, with numerous companies vying for market share. MCOA faces competition from established players and emerging brands. The regulatory landscape is complex and varies by state, creating both opportunities and challenges for companies in this sector. The global cannabis market is projected to reach significant growth in the coming years, driven by increasing legalization and acceptance of cannabis and CBD products.
Kilit Müşteriler
- Individual consumers seeking wellness and pain relief products.
- Retailers, including smoke shops, vape shops, and c-stores.
- Wholesalers distributing hemp and CBD products.
- Affiliate marketers promoting hempSMART products.
Finansallar
Grafik & Bilgi
Marijuana Company of America, Inc. (MCOA) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
Stocks That Hit 52-Week Lows On Friday
· 28 Şub 2020
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
MCOA için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
MCOA için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, MCOA'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Jesus Quintero
CEO
Jesus Quintero serves as the CEO of Marijuana Company of America, Inc. His background includes experience in managing and developing businesses, with a focus on the cannabis and CBD industry. He has been instrumental in guiding the company's strategic direction and product development efforts. His expertise lies in identifying market opportunities and building partnerships to expand the company's reach. He is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Sicil: Under Jesus Quintero's leadership, Marijuana Company of America, Inc. has focused on expanding its hempSMART product line and establishing a presence in the competitive CBD market. Key milestones include the development of hempSMART Brain and the expansion of the company's online sales channels. He has also focused on building relationships with affiliate marketers to drive sales and increase brand awareness. His tenure has been marked by efforts to navigate the evolving regulatory landscape and position the company for growth.
MCOA OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Company of America, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility. This tier is often populated by shell companies, companies in distress, or those with minimal operations.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure and potential for lack of transparency.
- Low trading volume and illiquidity.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Potential for delisting or suspension of trading.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established hempSMART brand.
- Online presence and direct-to-consumer sales channel.
- Distribution network through cdistro.com.
- Management team in place.
MCOA Hakkında Sıkça Sorulan Sorular
MCOA için değerlendirilmesi gereken temel faktörler nelerdir?
Marijuana Company of America, Inc. (MCOA) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Temel güçlü yan: Established hempSMART brand.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.. Bu bir finansal tavsiye değildir.
MCOA MoonshotScore'u nedir?
MCOA şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
MCOA verileri ne sıklıkla güncellenir?
MCOA fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler MCOA hakkında ne diyor?
MCOA için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
MCOA'a yatırım yapmanın riskleri nelerdir?
MCOA için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
MCOA'ın P/E oranı nedir?
MCOA için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için MCOA'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
MCOA aşırı değerli mi, yoksa düşük değerli mi?
Marijuana Company of America, Inc. (MCOA)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
MCOA'ın temettü verimi nedir?
Marijuana Company of America, Inc. (MCOA) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited information available due to OTC listing.
- Financial data may not be fully reliable.
- AI analysis pending.